HOTAIR and neoplasm: Recently, a computer-aided structure-based drug design method has been able to develop small molecule inhibitor of HOTAIR (e.g., AC1NOD4Q) which particularly interferes with the HOTAIR/EZH2 interaction and prevents tumor metastasis in breast cancer models (Ren et al., 2019a).